Seminars

Wednesday, September 16, 2020

Dr. Christina Angeles and Dr. Peggy Hsu Present Cancer Biology Research Seminar

4:00 PM to 5:00 PM

Join Zoom Meeting
Meeting ID: 930 9148 1605
Passcode: 649361

Seminars

Wednesday, September 9, 2020

Dr. Carl Koschmann and Dr. Phil Palmbos Present Cancer Biology Research Seminar

4:00 PM to 5:00 PM

Join Zoom Meeting
Meeting ID: 987 8869 1428
Passcode: 633038

Seminars

Wednesday, September 2, 2020

Dr. Laura Kresty and Dr. Qing Li Present Cancer Biology Research Seminar

4:00 PM

Join Zoom Meeting
Meeting ID: 916 0504 9067
Passcode: 555800

Seminars

Wednesday, July 22, 2020

Barbara Nelson (Lyssiotis Lab) Presents Cancer Biology Thesis Defense

1:00 PM to 2:00 PM

Join Zoom Meeting https://umich.zoom.us/j/98702807191 Meeting ID: 987 0280 7191 Password: 488890

Please join us for Barbara Nelson's Thesis Defense Seminar, "Defining Roles of Metabolic Reprogramming in Pancreatic Tumorigenesis and Tumor Maintenance"

Seminars

Wednesday, July 15, 2020

Morgan Penny (Hammer Lab) Presents Cancer Biology Thesis Defense

1:00 PM to 2:00 PM

Bluejeans Link: https://bluejeans.com/3582613537 Meeting ID: 358 261 353 7

Please join us for Morgan Penny's Thesis Defense Seminar, "Targeting oncogenic Wnt/β-catenin signaling in adrenocortical carcinoma disrupts extracellular matrix expression and impairs tumor growth."

Seminars

Tuesday, May 26, 2020

Christie Rodriguez Ramirez (Nor Lab) Presents Cancer Biology Thesis Defense

10:00 AM to 11:00 AM

Bluejeans Link: https://bluejeans.com/139741076 Meeting ID: 139 741 076

Please join us for Christie Rodriguez Ramirez's Thesis Defense Seminar, "p53 regulates stemness in mucoepidermoid carcinoma".

Seminars

Wednesday, July 15, 2020

Seminar: Dr. Maria Castro

4:00 PM to 5:00 PM

Join Zoom Meeting Meeting ID: 954 8771 6551 Password: 001952

Cancer Biology faculty member, Maria Castro, Ph.D., RC Schneider Professor of Neurosurgery and Cell and Developmental Biology, will present a talk, “Epigenetic reprogramming of the tumor immune microenvironment in mutant IDH1 gliomas: implications for immune-mediated therapies”

Seminars